Clinical Trials List
Protocol Number202109031MIPD
2022-02-01 - 2027-01-31
Phase II
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 張端瑩 Division of Hematology & Oncology
- 李佳真 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 林季宏 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 黃柏翔 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
42 participants
-
Global
42 participants
